Background
Pregnant women represent a potentially high‐risk population in the COVID‐19 pandemic.
Objective
To summarize clinical characteristics and outcomes among pregnant women hospitalized with COVID‐19.
Search strategy
Relevant databases were searched up until May 29, 2020.
Selection criteria
Case series/reports of hospitalized pregnant women with laboratory‐confirmed COVID‐19.
Data collection and analysis
PRISMA guidelines were followed. Methodologic quality was assessed via NIH assessment tools.
Main results
Overall, 63 observational studies of 637 women (84.6% in third trimester) with laboratory‐confirmed SARS‐CoV‐2 infection were included. Most (76.5%) women experienced mild disease. Maternal fatality, stillbirth, and neonatal fatality rates were 1.6%, 1.4%, and 1.0%, respectively. Older age, obesity, diabetes mellitus, and raised serum D‐dimer and interleukin‐6 were predictive of poor outcomes. Overall, 33.7% of live births were preterm, of which half were iatrogenic among women with mild COVID‐19 and no complications. Most women underwent cesarean despite lacking a clear indication. Eight (2.0%) neonates had positive nasopharyngeal swabs after delivery and developed chest infection within 48 hours.
Conclusions
Advanced gestation, maternal age, obesity, diabetes mellitus, and a combination of elevated D‐dimer and interleukin‐6 levels are predictive of poor pregnancy outcomes in COVID‐19. The rate of iatrogenic preterm birth and cesarean delivery is high; vertical transmission may be possible but has not been proved.